| Name | N-[4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenyl]benzamide |
|---|---|
| Synonyms |
Aurora kinase inhibitor-2
quinazoline deriv. 1 IUN-70219 Benzamide, N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl] 4-(4'-Benzamidoanilino)-6,7-dimethoxyquinazoline N-(4-((6,7-Dimethoxyquinazolin-4-yl)amino)phenyl)benzamide Aurora kinase inhibitor-2, 10 mM in DMSO Anilinoquinazoline1 inhibit,Aurora-A,Aurora kinase inhibitor2,Aurora Kinase,ATP-competitive,Aurora kinase inhibitor 2,Aurora kinase inhibitor-2,Aurora-B,Inhibitor |
| Description | Aurora kinase inhibitor-2 is a selective and ATP-competitive Aurora kinase inhibitor with IC50s of 310 nM and 240 nM for Aurora A and Aurora B, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
Aurora A:310 nM (IC50) Aurora B:240 nM (IC50) |
| In Vitro | Aurora kinase inhibitor-2 (Compound 1) shows excellent levels of Aurora A enzyme inhibition and is also effective in an MCF7 cellular anti-proliferative assay (IC50 value of 1.25 µM)[2]. |
| References |
| Molecular Formula | C23H20N4O3 |
|---|---|
| Molecular Weight | 400.43000 |
| Exact Mass | 400.15400 |
| PSA | 85.37000 |
| LogP | 4.78890 |